<DOC>
	<DOCNO>NCT01375400</DOCNO>
	<brief_summary>Aspirin anti-platelet medication use acute phase ischemic stroke . The investigator would like study laboratory effect first oral 300 mg dose aspirin , give hospital , ischemic event . The principal hypothesis platelet activity would able recover day could lead ischemic recurrence . Two blood sample accomplish . The first 2 hour aspirin intake second 23 hour . Photometric aggregometry perform arachidonic acid collagen induce platelet aggregation , measure thromboxan B2 level reticular platelet count .</brief_summary>
	<brief_title>Effect Aspirin Acute Phase Cerebral Ischemic Event .</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Adult men woman Ischemic stroke less 48 hour Signed consent Danger prescription aspirin ( haemorrhagic risk ... ) Prescription heparin VKA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>aspirin</keyword>
	<keyword>platelet</keyword>
</DOC>